Economic Evaluation of NHS England’s Type 2 Diabetes Path to Remission Pilot Scheme: Evidence From Real-World Data and Patient Simulation Modelling
A nationwide rollout of T2DPR would have significant implications for healthcare budgets and opportunity costs, given potentially high demand driven by the high incidence of T2D among eligible adults. Cost effectiveness depends on the weight and HbA1c regain experienced by service users after discharge. Future research should explore these outcomes, including potential inequalities in regain trajectories.
Authors
- Tamara Brown (ORCID: https://orcid.org/0000-0003-1285-7098)
- Adam Martin (ORCID: https://orcid.org/0000-0002-2559-6483)
- Miaoqing Yang (ORCID: https://orcid.org/0000-0001-7975-374X)
- Tayamika Kamwanja (ORCID: https://orcid.org/0000-0002-1020-6235)
- Louisa Ells (ORCID: https://orcid.org/0000-0003-0559-4832)
- Davide Tebaldi (ORCID: https://orcid.org/0000-0001-6450-5487)
Institutions
- University of Leeds (GB)
- Leeds Beckett University (GB)
Publication Details
- Journal
- PharmacoEconomics - Open
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1007/s41669-025-00622-x
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Research
- Department of Health and Social Care
- Medical Research Council